UniProtKB - P84022 (SMAD3_HUMAN)
Mothers against decapentaplegic homolog 3
SMAD3
Functioni
Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD3/SMAD4 complex, activates transcription. Also can form a SMAD3/SMAD4/JUN/FOS complex at the AP-1/SMAD site to regulate TGF-beta-mediated transcription. Has an inhibitory effect on wound healing probably by modulating both growth and migration of primary keratinocytes and by altering the TGF-mediated chemotaxis of monocytes. This effect on wound healing appears to be hormone-sensitive. Regulator of chondrogenesis and osteogenesis and inhibits early healing of bone fractures. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator.
11 PublicationsSites
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Sitei | 40 | Required for trimerization | 1 | |
Sitei | 41 | Required for interaction with DNA and JUN and for functional cooperation with JUN | 1 | |
Metal bindingi | 64 | Zinc | 1 | |
Metal bindingi | 109 | Zinc | 1 | |
Metal bindingi | 121 | Zinc | 1 | |
Metal bindingi | 126 | Zinc | 1 |
GO - Molecular functioni
- beta-catenin binding Source: Ensembl
- bHLH transcription factor binding Source: BHF-UCL
- chromatin DNA binding Source: Ensembl
- cis-regulatory region sequence-specific DNA binding Source: UniProtKB
- collagen binding Source: Ensembl
- co-SMAD binding Source: BHF-UCL
- DEAD/H-box RNA helicase binding Source: BHF-UCL
- DNA binding Source: ARUK-UCL
- DNA-binding transcription activator activity, RNA polymerase II-specific Source: BHF-UCL
- DNA-binding transcription factor activity Source: UniProtKB
- DNA-binding transcription factor activity, RNA polymerase II-specific Source: NTNU_SB
- DNA-binding transcription factor binding Source: BHF-UCL
- DNA-binding transcription repressor activity Source: ARUK-UCL
- glucocorticoid receptor binding Source: CAFA
- identical protein binding Source: IntAct
- I-SMAD binding Source: GO_Central
- mineralocorticoid receptor binding Source: CAFA
- nuclear receptor binding Source: BHF-UCL
- phosphatase binding Source: UniProtKB
- promoter-specific chromatin binding Source: Ensembl
- protein homodimerization activity Source: BHF-UCL
- protein kinase binding Source: UniProtKB
- RNA polymerase II cis-regulatory region sequence-specific DNA binding Source: GO_Central
- RNA polymerase II-specific DNA-binding transcription factor binding Source: BHF-UCL
- R-SMAD binding Source: UniProtKB
- sequence-specific DNA binding Source: BHF-UCL
- sterol response element binding Source: ARUK-UCL
- transcription cis-regulatory region binding Source: BHF-UCL
- transcription coactivator binding Source: UniProtKB
- transforming growth factor beta receptor binding Source: BHF-UCL
- ubiquitin binding Source: UniProtKB
- ubiquitin protein ligase binding Source: BHF-UCL
- zinc ion binding Source: UniProtKB
GO - Biological processi
- activation of cysteine-type endopeptidase activity involved in apoptotic process Source: BHF-UCL
- activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway Source: Ensembl
- activin receptor signaling pathway Source: BHF-UCL
- adrenal gland development Source: Ensembl
- anatomical structure morphogenesis Source: GO_Central
- BMP signaling pathway Source: GO_Central
- cell-cell junction organization Source: BHF-UCL
- cell differentiation Source: GO_Central
- cellular response to transforming growth factor beta stimulus Source: CAFA
- cellular response to virus Source: Ensembl
- developmental growth Source: Ensembl
- embryonic cranial skeleton morphogenesis Source: Ensembl
- embryonic foregut morphogenesis Source: Ensembl
- embryonic pattern specification Source: Ensembl
- endoderm development Source: Ensembl
- extrinsic apoptotic signaling pathway Source: BHF-UCL
- heart looping Source: Ensembl
- immune response Source: BHF-UCL
- immune system development Source: Ensembl
- in utero embryonic development Source: Ensembl
- JNK cascade Source: Ensembl
- lens fiber cell differentiation Source: Ensembl
- liver development Source: Ensembl
- mesoderm formation Source: Ensembl
- negative regulation of apoptotic process Source: Ensembl
- negative regulation of cardiac muscle hypertrophy in response to stress Source: Ensembl
- negative regulation of cell growth Source: BHF-UCL
- negative regulation of cell population proliferation Source: BHF-UCL
- negative regulation of cytosolic calcium ion concentration Source: BHF-UCL
- negative regulation of fat cell differentiation Source: BHF-UCL
- negative regulation of inflammatory response Source: Ensembl
- negative regulation of lung blood pressure Source: Ensembl
- negative regulation of osteoblast differentiation Source: Ensembl
- negative regulation of osteoblast proliferation Source: Ensembl
- negative regulation of protein catabolic process Source: Ensembl
- negative regulation of transcription by RNA polymerase II Source: ARUK-UCL
- negative regulation of wound healing Source: Ensembl
- nodal signaling pathway Source: BHF-UCL
- osteoblast development Source: Ensembl
- paraxial mesoderm morphogenesis Source: Ensembl
- pericardium development Source: Ensembl
- positive regulation of alkaline phosphatase activity Source: Ensembl
- positive regulation of bone mineralization Source: Ensembl
- positive regulation of canonical Wnt signaling pathway Source: Ensembl
- positive regulation of cell migration Source: Ensembl
- positive regulation of chondrocyte differentiation Source: Ensembl
- positive regulation of DNA-binding transcription factor activity Source: BHF-UCL
- positive regulation of epithelial to mesenchymal transition Source: BHF-UCL
- positive regulation of extracellular matrix assembly Source: BHF-UCL
- positive regulation of focal adhesion assembly Source: Ensembl
- positive regulation of gene expression Source: BHF-UCL
- positive regulation of interleukin-1 beta production Source: Ensembl
- positive regulation of nitric oxide biosynthetic process Source: BHF-UCL
- positive regulation of positive chemotaxis Source: Ensembl
- positive regulation of pri-miRNA transcription by RNA polymerase II Source: BHF-UCL
- positive regulation of protein import into nucleus Source: BHF-UCL
- positive regulation of stress fiber assembly Source: Ensembl
- positive regulation of transcription, DNA-templated Source: BHF-UCL
- positive regulation of transcription by RNA polymerase II Source: UniProtKB
- positive regulation of transforming growth factor beta3 production Source: Ensembl
- primary miRNA processing Source: BHF-UCL
- protein stabilization Source: Ensembl
- regulation of binding Source: Ensembl
- regulation of epithelial cell proliferation Source: Ensembl
- regulation of immune response Source: Ensembl
- regulation of pri-miRNA transcription by RNA polymerase II Source: ARUK-UCL
- regulation of striated muscle tissue development Source: Ensembl
- regulation of transcription, DNA-templated Source: ComplexPortal
- regulation of transcription by RNA polymerase II Source: NTNU_SB
- regulation of transforming growth factor beta2 production Source: BHF-UCL
- regulation of transforming growth factor beta receptor signaling pathway Source: BHF-UCL
- response to hypoxia Source: BHF-UCL
- signal transduction involved in regulation of gene expression Source: Ensembl
- SMAD protein complex assembly Source: BHF-UCL
- SMAD protein signal transduction Source: GO_Central
- somitogenesis Source: Ensembl
- T cell activation Source: Ensembl
- thyroid gland development Source: Ensembl
- transdifferentiation Source: Ensembl
- transforming growth factor beta receptor signaling pathway Source: UniProtKB
- ureteric bud development Source: Ensembl
- wound healing Source: BHF-UCL
Keywordsi
Molecular function | DNA-binding |
Biological process | Host-virus interaction, Transcription, Transcription regulation |
Ligand | Metal-binding, Zinc |
Enzyme and pathway databases
PathwayCommonsi | P84022 |
Reactomei | R-HSA-1181150, Signaling by NODAL R-HSA-1502540, Signaling by Activin R-HSA-2173788, Downregulation of TGF-beta receptor signaling R-HSA-2173789, TGF-beta receptor signaling activates SMADs R-HSA-2173795, Downregulation of SMAD2/3:SMAD4 transcriptional activity R-HSA-2173796, SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription R-HSA-3304356, SMAD2/3 Phosphorylation Motif Mutants in Cancer R-HSA-3311021, SMAD4 MH2 Domain Mutants in Cancer R-HSA-3315487, SMAD2/3 MH2 Domain Mutants in Cancer R-HSA-3656532, TGFBR1 KD Mutants in Cancer R-HSA-5689880, Ub-specific processing proteases R-HSA-8941855, RUNX3 regulates CDKN1A transcription R-HSA-8952158, RUNX3 regulates BCL2L11 (BIM) transcription R-HSA-9008059, Interleukin-37 signaling R-HSA-9013695, NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9615017, FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes R-HSA-9617828, FOXO-mediated transcription of cell cycle genes |
SignaLinki | P84022 |
SIGNORi | P84022 |
Protein family/group databases
MoonDBi | P84022, Predicted |
Names & Taxonomyi
Protein namesi | Recommended name: Mothers against decapentaplegic homolog 3Short name: MAD homolog 3 Short name: Mad3 Short name: Mothers against DPP homolog 3 Short name: hMAD-3 Alternative name(s): JV15-2 SMAD family member 3 Short name: SMAD 3 Short name: Smad3 Short name: hSMAD3 |
Gene namesi | Name:SMAD3 Synonyms:MADH3 |
Organismi | Homo sapiens (Human) |
Taxonomic identifieri | 9606 [NCBI] |
Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Proteomesi |
|
Organism-specific databases
HGNCi | HGNC:6769, SMAD3 |
MIMi | 603109, gene |
neXtProti | NX_P84022 |
VEuPathDBi | HostDB:ENSG00000166949 |
Subcellular locationi
Nucleus
- Nucleus 8 Publications
Cytoplasm and Cytosol
- Cytoplasm 8 Publications
Note: Cytoplasmic and nuclear in the absence of TGF-beta. On TGF-beta stimulation, migrates to the nucleus when complexed with SMAD4 (PubMed:15799969, PubMed:21145499). Through the action of the phosphatase PPM1A, released from the SMAD2/SMAD4 complex, and exported out of the nucleus by interaction with RANBP1 (PubMed:16751101, PubMed:19289081). Co-localizes with LEMD3 at the nucleus inner membrane (PubMed:15601644). MAPK-mediated phosphorylation appears to have no effect on nuclear import (PubMed:19218245). PDPK1 prevents its nuclear translocation in response to TGF-beta (PubMed:17327236). Localized mainly to the nucleus in the early stages of embryo development with expression becoming evident in the cytoplasm of the inner cell mass at the blastocyst stage (By similarity).By similarity7 Publications
Cytosol
- cytosol Source: HPA
Nucleus
- heteromeric SMAD protein complex Source: BHF-UCL
- nuclear inner membrane Source: UniProtKB
- nucleoplasm Source: HPA
- nucleus Source: UniProtKB
Plasma Membrane
- plasma membrane Source: Ensembl
Other locations
- chromatin Source: BHF-UCL
- cytoplasm Source: UniProtKB
- receptor complex Source: BHF-UCL
- SMAD protein complex Source: UniProtKB
- transcription regulator complex Source: UniProtKB
Keywords - Cellular componenti
Cytoplasm, NucleusPathology & Biotechi
Involvement in diseasei
Colorectal cancer (CRC)1 Publication
Loeys-Dietz syndrome 3 (LDS3)2 Publications
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Natural variantiVAR_067051 | 112 | A → V in LDS3. 1 PublicationCorresponds to variant dbSNP:rs387906854EnsemblClinVar. | 1 | |
Natural variantiVAR_067047 | 239 | E → K in LDS3. 1 PublicationCorresponds to variant dbSNP:rs387906853EnsemblClinVar. | 1 | |
Natural variantiVAR_065578 | 261 | T → I in LDS3. 1 PublicationCorresponds to variant dbSNP:rs387906851EnsemblClinVar. | 1 | |
Natural variantiVAR_067048 | 279 | R → K in LDS3. 1 PublicationCorresponds to variant dbSNP:rs387906852EnsemblClinVar. | 1 | |
Natural variantiVAR_065579 | 287 | R → W in LDS3. 1 PublicationCorresponds to variant dbSNP:rs387906850EnsemblClinVar. | 1 |
Mutagenesis
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Mutagenesisi | 8 | T → V: Reduced phosphorylation, increased transcriptional and antiproliferative activities. Further increase in transcriptional and antiproliferative activities; when associated with V-179 and A-213. 1 Publication | 1 | |
Mutagenesisi | 33 | K → R: Slightly decreased monoubiquitination. 1 Publication | 1 | |
Mutagenesisi | 40 | K → A: Little effect on interaction with DNA or JUN. Abolishes interaction with DNA and JUN; when associated with A-41; A-43 and A-44. 1 Publication | 1 | |
Mutagenesisi | 41 | K → A: Greatly reduced interaction with DNA and JUN. Abolishes interaction with DNA and JUN; when associated with A-40; A-44 and A-43. 1 Publication | 1 | |
Mutagenesisi | 43 | K → A: Little effect on interaction with DNA or JUN. Abolishes interaction with DNA and JUN; when associated with A-40; A-41 and A-44. 1 Publication | 1 | |
Mutagenesisi | 44 | K → A: Little effect on interaction with DNA or JUN. Abolishes interaction with JUN; when associated with A-40; A-41 and A-43. 1 Publication | 1 | |
Mutagenesisi | 53 | K → R: Slightly decreased monoubiquitination. 1 Publication | 1 | |
Mutagenesisi | 74 | R → D: Reduced interaction with JUN. Loss of transcriptional activity and cooperation with JUN. 1 Publication | 1 | |
Mutagenesisi | 81 | K → R: Decreased monoubiquitination. 1 Publication | 1 | |
Mutagenesisi | 179 | T → V: Reduced phosphorylation, increased transcriptional and increased antiproliferative activities. Further increase in transcriptional and antiproliferative activities; when associated with V-8 and A-213. 3 Publications | 1 | |
Mutagenesisi | 204 | S → A: Increased transcriptional activity. Further increased transcriptional activity; when associated with S-208. 3 Publications | 1 | |
Mutagenesisi | 208 | S → A: Increased transcriptional activity. Further increased transcriptional activity; when associated with S-208. 3 Publications | 1 | |
Mutagenesisi | 213 | S → A: Reduced phosphorylation. Increased transcriptional and antiproliferative activities. Further increase in transcriptional and antiproliferative activities; when associated with V-8 and V-179. 1 Publication | 1 | |
Mutagenesisi | 333 | K → R: No effect on acetylation. Completely abolishes acetylation and 97% reduction in transcriptional activity; when associated with R-341; R-378 and R-409. 1 Publication | 1 | |
Mutagenesisi | 341 | K → R: No effect on acetylation. Completely abolishes acetylation and 97% reduction in transcriptional activity; when associated with R-333; R-378 and R-409. 1 Publication | 1 | |
Mutagenesisi | 378 | K → Q: Increased transcriptional activity. No further increase in transcriptional activity with EP300. 1 Publication | 1 | |
Mutagenesisi | 378 | K → R: Greatly reduced acetylation and 85% reduction in transcriptional activity. Completely abolishes acetylation and 97% reduction in transcriptional activity; when associated with R-333; R-341 and R-409. 1 Publication | 1 | |
Mutagenesisi | 409 | K → R: No effect on acetylation. Completely abolishes acetylation and 97% reduction in transcriptional activity; when associated with R-333; R-341 and R-378. 1 Publication | 1 | |
Mutagenesisi | 418 | S → A: Increased constitutive activity. 1 Publication | 1 | |
Mutagenesisi | 418 | S → D: Decreased activity. 1 Publication | 1 | |
Mutagenesisi | 422 – 425 | SSVS → AAVA: Does not abolish protein nuclear export. Abolishes almost completely acetylation. 3 Publications | 4 | |
Mutagenesisi | 422 – 425 | SSVS → EEVE: Forms heterotrimers. 3 Publications | 4 | |
Mutagenesisi | 422 – 425 | SSVS → RRVR: Diminishes cargo protein export. 3 Publications | 4 |
Keywords - Diseasei
Aortic aneurysm, Disease variantOrganism-specific databases
DisGeNETi | 4088 |
GeneReviewsi | SMAD3 |
MalaCardsi | SMAD3 |
MIMi | 114500, phenotype 613795, phenotype |
OpenTargetsi | ENSG00000166949 |
Orphaneti | 284984, Aneurysm-osteoarthritis syndrome 91387, Familial thoracic aortic aneurysm and aortic dissection |
PharmGKBi | PA30526 |
Miscellaneous databases
Pharosi | P84022, Tbio |
Chemistry databases
ChEMBLi | CHEMBL1293258 |
Genetic variation databases
BioMutai | SMAD3 |
DMDMi | 51338669 |
PTM / Processingi
Molecule processing
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Initiator methioninei | RemovedCombined sources | |||
ChainiPRO_0000090856 | 2 – 425 | Mothers against decapentaplegic homolog 3Add BLAST | 424 |
Amino acid modifications
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Modified residuei | 2 | N-acetylserineCombined sources | 1 | |
Modified residuei | 8 | Phosphothreonine; by CDK2 and CDK41 Publication | 1 | |
Cross-linki | 33 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)1 Publication | ||
Cross-linki | 81 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)1 Publication | ||
Modified residuei | 179 | Phosphothreonine; by CDK2, CDK4 and MAPK3 Publications | 1 | |
Modified residuei | 204 | Phosphoserine; by GSK3 and MAPKPROSITE-ProRule annotation3 Publications | 1 | |
Modified residuei | 208 | Phosphoserine; by MAPKPROSITE-ProRule annotation3 Publications | 1 | |
Modified residuei | 213 | Phosphoserine; by CDK2 and CDK4PROSITE-ProRule annotation1 Publication | 1 | |
Modified residuei | 378 | N6-acetyllysine1 Publication | 1 | |
Modified residuei | 416 | PhosphoserineCombined sources | 1 | |
Modified residuei | 418 | Phosphoserine; by CK1PROSITE-ProRule annotation1 Publication | 1 | |
Modified residuei | 422 | Phosphoserine; by TGFBR1PROSITE-ProRule annotationBy similarity | 1 | |
Modified residuei | 423 | Phosphoserine; by TGFBR1PROSITE-ProRule annotationBy similarity | 1 | |
Modified residuei | 425 | Phosphoserine; by TGFBR1PROSITE-ProRule annotationBy similarity | 1 |
Post-translational modificationi
Keywords - PTMi
Acetylation, ADP-ribosylation, Isopeptide bond, Phosphoprotein, Ubl conjugationProteomic databases
EPDi | P84022 |
jPOSTi | P84022 |
MassIVEi | P84022 |
MaxQBi | P84022 |
PaxDbi | P84022 |
PeptideAtlasi | P84022 |
PRIDEi | P84022 |
ProteomicsDBi | 26192 57743 [P84022-1] 57744 [P84022-2] 57745 [P84022-3] |
PTM databases
iPTMneti | P84022 |
PhosphoSitePlusi | P84022 |
SwissPalmi | P84022 |
Expressioni
Gene expression databases
Bgeei | ENSG00000166949, Expressed in amniotic fluid and 242 other tissues |
ExpressionAtlasi | P84022, baseline and differential |
Genevisiblei | P84022, HS |
Organism-specific databases
HPAi | ENSG00000166949, Low tissue specificity |
Interactioni
Subunit structurei
Monomer; in the absence of TGF-beta (PubMed:9670020). Homooligomer; in the presence of TGF-beta (PubMed:9670020). Heterotrimer; forms a heterotrimer in the presence of TGF-beta consisting of two molecules of C-terminally phosphorylated SMAD2 or SMAD3 and one of SMAD4 to form the transcriptionally active SMAD2/SMAD3-SMAD4 complex (PubMed:9670020, PubMed:11224571, PubMed:15799969, PubMed:15350224).
Part of a complex consisting of AIP1, ACVR2A, ACVR1B and SMAD3 (PubMed:9892009).
Forms a complex with SMAD2 and TRIM33 upon addition of TGF-beta (PubMed:16751102).
Found in a complex composed of SMAD3, RAN and XPO4; within the complex interacts directly with XPO4 (PubMed:16449645).
Component of the multimeric complex SMAD3/SMAD4/JUN/FOS which forms at the AP1 promoter site; required for synergistic transcriptional activity in response to TGF-beta (PubMed:9732876, PubMed:10995748).
Interacts (via an N-terminal domain) with JUN (via its basic DNA binding and leucine zipper domains); this interaction is essential for DNA binding and cooperative transcriptional activity in response to TGF-beta (PubMed:9732876, PubMed:10995748).
Identified in a complex that contains at least ZNF451, SMAD2, SMAD3 and SMAD4 (PubMed:24324267).
Interacts with PPM1A; the interaction dephosphorylates SMAD3 in the C-terminal SXS motif leading to disruption of the SMAD2/3-SMAD4 complex, nuclear export and termination of TGF-beta signaling (PubMed:16751101).
Interacts (via MH2 domain) with ZMIZ1 (via SP-RING-type domain); in the TGF-beta signaling pathway increases the activity of the SMAD3/SMAD4 transcriptional complex (PubMed:16777850).
Interacts (when phosphorylated) with RNF111; RNF111 acts as an enhancer of the transcriptional responses by mediating ubiquitination and degradation of SMAD3 inhibitors (PubMed:9311995).
Interacts (dephosphorylated form via the MH1 and MH2 domains) with RANBP3 (via its C-terminal R domain); the interaction results in the export of dephosphorylated SMAD3 out of the nucleus and termination of the TGF-beta signaling (PubMed:19289081).
Interacts (via MH2 domain) with LEMD3; the interaction represses SMAD3 transcriptional activity through preventing the formation of the heteromeric complex with SMAD4 and translocation to the nucleus (PubMed:15601644, PubMed:15647271).
Interacts (via the linker region) with EP300 (C-terminal); the interaction promotes SMAD3 acetylation and is enhanced by TGF-beta phosphorylation in the C-terminal of SMAD3 (PubMed:9843571, PubMed:15588252). This interaction can be blocked by competitive binding of adenovirus oncoprotein E1A to the same C-terminal site on EP300, which then results in partially inhibited SMAD3/SMAD4 transcriptional activity (PubMed:9843571, PubMed:15588252).
Interacts with TGFBR1 (PubMed:9311995).
Interacts with TGFB1I1 (PubMed:15561701).
Interacts with PRDM16 (PubMed:19049980).
Interacts with SNW1 (PubMed:11278756).
Interacts (via MH2 domain) with ZFYVE9 (PubMed:9865696, PubMed:12154125).
Interacts with HDAC1 (PubMed:19049980).
Interacts with TGIF2 (PubMed:11427533).
Interacts with SKOR1 (PubMed:17292623).
Interacts with SKOR2 (PubMed:16200078).
Interacts with DACH1; the interaction inhibits the TGF-beta signaling (PubMed:14525983).
Interacts with RBPMS (PubMed:17099224).
Interacts (via MH2 domain) with MECOM (PubMed:9665135, PubMed:15897867).
Interacts with WWTR1 (via its coiled-coil domain) (PubMed:18568018).
Interacts with SKI; the interaction represses SMAD3 transcriptional activity (PubMed:19049980).
Interacts with MEN1 (PubMed:11274402).
Interacts with IL1F7 (PubMed:20935647). Interaction with CSNK1G2 (PubMed:18794808).
Interacts with PDPK1 (via PH domain) (PubMed:17327236).
Interacts with DAB2; the interactions are enhanced upon TGF-beta stimulation (PubMed:11387212).
Interacts with USP15 (PubMed:21947082).
Interacts with PPP5C; the interaction decreases SMAD3 phosphorylation and protein levels (PubMed:22781750).
Interacts with LDLRAD4 (via the SMAD interaction motif) (PubMed:24627487).
Interacts with PMEPA1 (PubMed:20129061).
Interacts with ZNF451 (PubMed:24324267).
Interacts with ZFHX3 (PubMed:25105025).
Interacts weakly with ZNF8 (PubMed:12370310).
Interacts with STUB1, HSPA1A, HSPA1B, HSP90AA1 and HSP90AB1 (PubMed:24613385).
Interacts with YAP1 (when phosphorylated at 'Ser-127') (By similarity).
Interacts with AIP1 (By similarity).
Interacts (via MH2 domain) with CITED2 (via C-terminus) (By similarity).
Interacts with HGS (By similarity).
Interacts with WWP1 (By similarity).
Interacts with TTRAP (By similarity).
Interacts with FOXL2 (By similarity).
Interacts with PML (By similarity).
Interacts with NEDD4L; the interaction requires TGF-beta stimulation (By similarity).
Interacts with ZC3H3 (By similarity).
Interacts with TGIF.
Interacts with CREBBP.
Interacts with ATF2.
By similarity43 Publications(Microbial infection) Interacts with SARS-CoV nucleoprotein.
1 PublicationBinary interactionsi
P84022
GO - Molecular functioni
- beta-catenin binding Source: Ensembl
- bHLH transcription factor binding Source: BHF-UCL
- co-SMAD binding Source: BHF-UCL
- DEAD/H-box RNA helicase binding Source: BHF-UCL
- DNA-binding transcription factor binding Source: BHF-UCL
- glucocorticoid receptor binding Source: CAFA
- identical protein binding Source: IntAct
- I-SMAD binding Source: GO_Central
- mineralocorticoid receptor binding Source: CAFA
- nuclear receptor binding Source: BHF-UCL
- phosphatase binding Source: UniProtKB
- protein homodimerization activity Source: BHF-UCL
- protein kinase binding Source: UniProtKB
- RNA polymerase II-specific DNA-binding transcription factor binding Source: BHF-UCL
- R-SMAD binding Source: UniProtKB
- transcription coactivator binding Source: UniProtKB
- transforming growth factor beta receptor binding Source: BHF-UCL
- ubiquitin binding Source: UniProtKB
- ubiquitin protein ligase binding Source: BHF-UCL
Protein-protein interaction databases
BioGRIDi | 110263, 388 interactors |
ComplexPortali | CPX-1, SMAD2-SMAD3-SMAD4 complex CPX-12, SMAD3 homotrimer CPX-3252, SMAD3-SMAD4 complex CPX-6062, SMAD3-TTF-1 complex |
CORUMi | P84022 |
DIPi | DIP-29720N |
IntActi | P84022, 211 interactors |
MINTi | P84022 |
STRINGi | 9606.ENSP00000332973 |
Chemistry databases
BindingDBi | P84022 |
Miscellaneous databases
RNActi | P84022, protein |
Structurei
Secondary structure
3D structure databases
SMRi | P84022 |
ModBasei | Search... |
PDBe-KBi | Search... |
Miscellaneous databases
EvolutionaryTracei | P84022 |
Family & Domainsi
Domains and Repeats
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Domaini | 10 – 136 | MH1PROSITE-ProRule annotationAdd BLAST | 127 | |
Domaini | 232 – 425 | MH2PROSITE-ProRule annotationAdd BLAST | 194 |
Region
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Regioni | 137 – 231 | LinkerAdd BLAST | 95 | |
Regioni | 165 – 208 | DisorderedSequence analysisAdd BLAST | 44 | |
Regioni | 271 – 324 | Sufficient for interaction with XPO41 PublicationAdd BLAST | 54 |
Domaini
Sequence similaritiesi
Phylogenomic databases
eggNOGi | KOG3701, Eukaryota |
GeneTreei | ENSGT00940000153499 |
HOGENOMi | CLU_026736_0_0_1 |
InParanoidi | P84022 |
OMAi | MGSPNIR |
PhylomeDBi | P84022 |
TreeFami | TF314923 |
Family and domain databases
DisProti | DP01648 |
Gene3Di | 2.60.200.10, 1 hit 3.90.520.10, 1 hit |
IDEALi | IID00113 |
InterProi | View protein in InterPro IPR013790, Dwarfin IPR003619, MAD_homology1_Dwarfin-type IPR013019, MAD_homology_MH1 IPR017855, SMAD-like_dom_sf IPR001132, SMAD_dom_Dwarfin-type IPR008984, SMAD_FHA_dom_sf IPR036578, SMAD_MH1_sf |
PANTHERi | PTHR13703, PTHR13703, 1 hit |
Pfami | View protein in Pfam PF03165, MH1, 1 hit PF03166, MH2, 1 hit |
SMARTi | View protein in SMART SM00523, DWA, 1 hit SM00524, DWB, 1 hit |
SUPFAMi | SSF49879, SSF49879, 1 hit SSF56366, SSF56366, 1 hit |
PROSITEi | View protein in PROSITE PS51075, MH1, 1 hit PS51076, MH2, 1 hit |
s (4+)i Sequence
Sequence statusi: Complete.
: The displayed sequence is further processed into a mature form. Sequence processingi
This entry describes 4 produced by isoformsialternative splicing. AlignAdd to basketThis entry has 4 described isoforms and 8 potential isoforms that are computationally mapped.Show allAlign All
This isoform has been chosen as the sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. canonicali
10 20 30 40 50
MSSILPFTPP IVKRLLGWKK GEQNGQEEKW CEKAVKSLVK KLKKTGQLDE
60 70 80 90 100
LEKAITTQNV NTKCITIPRS LDGRLQVSHR KGLPHVIYCR LWRWPDLHSH
110 120 130 140 150
HELRAMELCE FAFNMKKDEV CVNPYHYQRV ETPVLPPVLV PRHTEIPAEF
160 170 180 190 200
PPLDDYSHSI PENTNFPAGI EPQSNIPETP PPGYLSEDGE TSDHQMNHSM
210 220 230 240 250
DAGSPNLSPN PMSPAHNNLD LQPVTYCEPA FWCSISYYEL NQRVGETFHA
260 270 280 290 300
SQPSMTVDGF TDPSNSERFC LGLLSNVNRN AAVELTRRHI GRGVRLYYIG
310 320 330 340 350
GEVFAECLSD SAIFVQSPNC NQRYGWHPAT VCKIPPGCNL KIFNNQEFAA
360 370 380 390 400
LLAQSVNQGF EAVYQLTRMC TIRMSFVKGW GAEYRRQTVT STPCWIELHL
410 420
NGPLQWLDKV LTQMGSPSIR CSSVS
Computationally mapped potential isoform sequencesi
There are 8 potential isoforms mapped to this entry.BLASTAlignShow allAdd to basketH3BVD1 | H3BVD1_HUMAN | Mothers against decapentaplegic hom... | SMAD3 | 213 | Annotation score: | ||
H3BP09 | H3BP09_HUMAN | Mothers against decapentaplegic hom... | SMAD3 | 114 | Annotation score: | ||
H0YNV1 | H0YNV1_HUMAN | Mothers against decapentaplegic hom... | SMAD3 | 84 | Annotation score: | ||
H0YKE2 | H0YKE2_HUMAN | Mothers against decapentaplegic hom... | SMAD3 | 112 | Annotation score: | ||
H0YL71 | H0YL71_HUMAN | Mothers against decapentaplegic hom... | SMAD3 | 92 | Annotation score: | ||
H0YMP2 | H0YMP2_HUMAN | Mothers against decapentaplegic hom... | SMAD3 | 63 | Annotation score: | ||
H3BQ00 | H3BQ00_HUMAN | Mothers against decapentaplegic hom... | SMAD3 | 156 | Annotation score: | ||
H0YMY0 | H0YMY0_HUMAN | Mothers against decapentaplegic hom... | SMAD3 | 96 | Annotation score: |
Experimental Info
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Sequence conflicti | 178 | E → EVGTWAAQAGL in BAA22032 (PubMed:9464505).Curated | 1 | |
Sequence conflicti | 360 | F → L in BAH13315 (PubMed:14702039).Curated | 1 |
Natural variant
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Natural variantiVAR_067051 | 112 | A → V in LDS3. 1 PublicationCorresponds to variant dbSNP:rs387906854EnsemblClinVar. | 1 | |
Natural variantiVAR_052021 | 170 | I → V. Corresponds to variant dbSNP:rs35874463EnsemblClinVar. | 1 | |
Natural variantiVAR_067047 | 239 | E → K in LDS3. 1 PublicationCorresponds to variant dbSNP:rs387906853EnsemblClinVar. | 1 | |
Natural variantiVAR_065578 | 261 | T → I in LDS3. 1 PublicationCorresponds to variant dbSNP:rs387906851EnsemblClinVar. | 1 | |
Natural variantiVAR_067048 | 279 | R → K in LDS3. 1 PublicationCorresponds to variant dbSNP:rs387906852EnsemblClinVar. | 1 | |
Natural variantiVAR_065579 | 287 | R → W in LDS3. 1 PublicationCorresponds to variant dbSNP:rs387906850EnsemblClinVar. | 1 | |
Natural variantiVAR_036474 | 393 | P → L in a colorectal cancer sample; somatic mutation. 1 Publication | 1 |
Alternative sequence
Feature key | Position(s) | DescriptionActions | Graphical view | Length |
---|---|---|---|---|
Alternative sequenceiVSP_045348 | 1 – 195 | Missing in isoform 4. 1 PublicationAdd BLAST | 195 | |
Alternative sequenceiVSP_043793 | 1 – 105 | Missing in isoform 3. 1 PublicationAdd BLAST | 105 | |
Alternative sequenceiVSP_042900 | 1 – 68 | MSSIL…CITIP → MSCLHPRQTWKGAALVHRKA WWMG in isoform 2. 1 PublicationAdd BLAST | 68 |
Sequence databases
Select the link destinations: EMBLi GenBanki DDBJi Links Updated | U68019 mRNA Translation: AAB80960.1 U76622 mRNA Translation: AAB18967.1 AB004930 Genomic DNA Translation: BAA22032.1 AF025300 , AF025293, AF025294, AF025295, AF025296, AF025297, AF025298, AF025299 Genomic DNA Translation: AAL68976.1 AK290881 mRNA Translation: BAF83570.1 AK298139 mRNA Translation: BAH12731.1 AK300614 mRNA Translation: BAH13315.1 AK316017 mRNA Translation: BAH14388.1 AC012568 Genomic DNA No translation available. AC087482 Genomic DNA No translation available. CH471082 Genomic DNA Translation: EAW77788.1 BC050743 mRNA Translation: AAH50743.1 |
CCDSi | CCDS10222.1 [P84022-1] CCDS45288.1 [P84022-2] CCDS53950.1 [P84022-3] CCDS53951.1 [P84022-4] |
PIRi | S71798 |
RefSeqi | NP_001138574.1, NM_001145102.1 [P84022-3] NP_001138575.1, NM_001145103.1 [P84022-2] NP_001138576.1, NM_001145104.1 [P84022-4] NP_005893.1, NM_005902.3 [P84022-1] |
Genome annotation databases
Ensembli | ENST00000327367; ENSP00000332973; ENSG00000166949 ENST00000439724; ENSP00000401133; ENSG00000166949 [P84022-2] ENST00000537194; ENSP00000445348; ENSG00000166949 [P84022-4] ENST00000540846; ENSP00000437757; ENSG00000166949 [P84022-3] ENST00000679624; ENSP00000505445; ENSG00000166949 [P84022-3] ENST00000681239; ENSP00000505641; ENSG00000166949 [P84022-3] |
GeneIDi | 4088 |
KEGGi | hsa:4088 |
MANE-Selecti | ENST00000327367.9; ENSP00000332973.4; NM_005902.4; NP_005893.1 |
UCSCi | uc002aqj.4, human [P84022-1] |
Keywords - Coding sequence diversityi
Alternative splicingSimilar proteinsi
Cross-referencesi
Sequence databases
Select the link destinations: EMBLi GenBanki DDBJi Links Updated | U68019 mRNA Translation: AAB80960.1 U76622 mRNA Translation: AAB18967.1 AB004930 Genomic DNA Translation: BAA22032.1 AF025300 , AF025293, AF025294, AF025295, AF025296, AF025297, AF025298, AF025299 Genomic DNA Translation: AAL68976.1 AK290881 mRNA Translation: BAF83570.1 AK298139 mRNA Translation: BAH12731.1 AK300614 mRNA Translation: BAH13315.1 AK316017 mRNA Translation: BAH14388.1 AC012568 Genomic DNA No translation available. AC087482 Genomic DNA No translation available. CH471082 Genomic DNA Translation: EAW77788.1 BC050743 mRNA Translation: AAH50743.1 |
CCDSi | CCDS10222.1 [P84022-1] CCDS45288.1 [P84022-2] CCDS53950.1 [P84022-3] CCDS53951.1 [P84022-4] |
PIRi | S71798 |
RefSeqi | NP_001138574.1, NM_001145102.1 [P84022-3] NP_001138575.1, NM_001145103.1 [P84022-2] NP_001138576.1, NM_001145104.1 [P84022-4] NP_005893.1, NM_005902.3 [P84022-1] |
3D structure databases
Select the link destinations: PDBei RCSB PDBi PDBji Links Updated | PDB entry | Method | Resolution (Å) | Chain | Positions | PDBsum |
1MHD | X-ray | 2.80 | A/B | 1-132 | [»] | |
1MJS | X-ray | 1.91 | A | 229-425 | [»] | |
1MK2 | X-ray | 2.74 | A | 220-425 | [»] | |
1OZJ | X-ray | 2.40 | A/B | 1-144 | [»] | |
1U7F | X-ray | 2.60 | A/C | 228-425 | [»] | |
2LAJ | NMR | - | B | 202-211 | [»] | |
2LB2 | NMR | - | B | 178-189 | [»] | |
5OD6 | X-ray | 2.00 | A/B | 11-135 | [»] | |
5ODG | X-ray | 2.12 | A/B | 11-135 | [»] | |
5XOC | X-ray | 2.40 | A | 220-416 | [»] | |
6YIB | X-ray | 1.70 | P | 417-425 | [»] | |
6ZMN | X-ray | 2.33 | A/B | 10-136 | [»] | |
SMRi | P84022 | |||||
ModBasei | Search... | |||||
PDBe-KBi | Search... |
Protein-protein interaction databases
BioGRIDi | 110263, 388 interactors |
ComplexPortali | CPX-1, SMAD2-SMAD3-SMAD4 complex CPX-12, SMAD3 homotrimer CPX-3252, SMAD3-SMAD4 complex CPX-6062, SMAD3-TTF-1 complex |
CORUMi | P84022 |
DIPi | DIP-29720N |
IntActi | P84022, 211 interactors |
MINTi | P84022 |
STRINGi | 9606.ENSP00000332973 |
Chemistry databases
BindingDBi | P84022 |
ChEMBLi | CHEMBL1293258 |
Protein family/group databases
MoonDBi | P84022, Predicted |
PTM databases
iPTMneti | P84022 |
PhosphoSitePlusi | P84022 |
SwissPalmi | P84022 |
Genetic variation databases
BioMutai | SMAD3 |
DMDMi | 51338669 |
Proteomic databases
EPDi | P84022 |
jPOSTi | P84022 |
MassIVEi | P84022 |
MaxQBi | P84022 |
PaxDbi | P84022 |
PeptideAtlasi | P84022 |
PRIDEi | P84022 |
ProteomicsDBi | 26192 57743 [P84022-1] 57744 [P84022-2] 57745 [P84022-3] |
Protocols and materials databases
ABCDi | P84022, 2 sequenced antibodies |
Antibodypediai | 26224, 2368 antibodies from 44 providers |
DNASUi | 4088 |
Genome annotation databases
Ensembli | ENST00000327367; ENSP00000332973; ENSG00000166949 ENST00000439724; ENSP00000401133; ENSG00000166949 [P84022-2] ENST00000537194; ENSP00000445348; ENSG00000166949 [P84022-4] ENST00000540846; ENSP00000437757; ENSG00000166949 [P84022-3] ENST00000679624; ENSP00000505445; ENSG00000166949 [P84022-3] ENST00000681239; ENSP00000505641; ENSG00000166949 [P84022-3] |
GeneIDi | 4088 |
KEGGi | hsa:4088 |
MANE-Selecti | ENST00000327367.9; ENSP00000332973.4; NM_005902.4; NP_005893.1 |
UCSCi | uc002aqj.4, human [P84022-1] |
Organism-specific databases
CTDi | 4088 |
DisGeNETi | 4088 |
GeneCardsi | SMAD3 |
GeneReviewsi | SMAD3 |
HGNCi | HGNC:6769, SMAD3 |
HPAi | ENSG00000166949, Low tissue specificity |
MalaCardsi | SMAD3 |
MIMi | 114500, phenotype 603109, gene 613795, phenotype |
neXtProti | NX_P84022 |
OpenTargetsi | ENSG00000166949 |
Orphaneti | 284984, Aneurysm-osteoarthritis syndrome 91387, Familial thoracic aortic aneurysm and aortic dissection |
PharmGKBi | PA30526 |
VEuPathDBi | HostDB:ENSG00000166949 |
GenAtlasi | Search... |
Phylogenomic databases
eggNOGi | KOG3701, Eukaryota |
GeneTreei | ENSGT00940000153499 |
HOGENOMi | CLU_026736_0_0_1 |
InParanoidi | P84022 |
OMAi | MGSPNIR |
PhylomeDBi | P84022 |
TreeFami | TF314923 |
Enzyme and pathway databases
PathwayCommonsi | P84022 |
Reactomei | R-HSA-1181150, Signaling by NODAL R-HSA-1502540, Signaling by Activin R-HSA-2173788, Downregulation of TGF-beta receptor signaling R-HSA-2173789, TGF-beta receptor signaling activates SMADs R-HSA-2173795, Downregulation of SMAD2/3:SMAD4 transcriptional activity R-HSA-2173796, SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription R-HSA-3304356, SMAD2/3 Phosphorylation Motif Mutants in Cancer R-HSA-3311021, SMAD4 MH2 Domain Mutants in Cancer R-HSA-3315487, SMAD2/3 MH2 Domain Mutants in Cancer R-HSA-3656532, TGFBR1 KD Mutants in Cancer R-HSA-5689880, Ub-specific processing proteases R-HSA-8941855, RUNX3 regulates CDKN1A transcription R-HSA-8952158, RUNX3 regulates BCL2L11 (BIM) transcription R-HSA-9008059, Interleukin-37 signaling R-HSA-9013695, NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9615017, FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes R-HSA-9617828, FOXO-mediated transcription of cell cycle genes |
SignaLinki | P84022 |
SIGNORi | P84022 |
Miscellaneous databases
BioGRID-ORCSi | 4088, 9 hits in 1072 CRISPR screens |
ChiTaRSi | SMAD3, human |
EvolutionaryTracei | P84022 |
GeneWikii | Mothers_against_decapentaplegic_homolog_3 |
GenomeRNAii | 4088 |
Pharosi | P84022, Tbio |
PROi | PR:P84022 |
RNActi | P84022, protein |
SOURCEi | Search... |
Gene expression databases
Bgeei | ENSG00000166949, Expressed in amniotic fluid and 242 other tissues |
ExpressionAtlasi | P84022, baseline and differential |
Genevisiblei | P84022, HS |
Family and domain databases
DisProti | DP01648 |
Gene3Di | 2.60.200.10, 1 hit 3.90.520.10, 1 hit |
IDEALi | IID00113 |
InterProi | View protein in InterPro IPR013790, Dwarfin IPR003619, MAD_homology1_Dwarfin-type IPR013019, MAD_homology_MH1 IPR017855, SMAD-like_dom_sf IPR001132, SMAD_dom_Dwarfin-type IPR008984, SMAD_FHA_dom_sf IPR036578, SMAD_MH1_sf |
PANTHERi | PTHR13703, PTHR13703, 1 hit |
Pfami | View protein in Pfam PF03165, MH1, 1 hit PF03166, MH2, 1 hit |
SMARTi | View protein in SMART SM00523, DWA, 1 hit SM00524, DWB, 1 hit |
SUPFAMi | SSF49879, SSF49879, 1 hit SSF56366, SSF56366, 1 hit |
PROSITEi | View protein in PROSITE PS51075, MH1, 1 hit PS51076, MH2, 1 hit |
MobiDBi | Search... |
Entry informationi
Entry namei | SMAD3_HUMAN | |
Accessioni | P84022Primary (citable) accession number: P84022 Secondary accession number(s): A8K4B6 Q9GKR4 | |
Entry historyi | Integrated into UniProtKB/Swiss-Prot: | July 5, 2004 |
Last sequence update: | July 5, 2004 | |
Last modified: | February 23, 2022 | |
This is version 197 of the entry and version 1 of the sequence. See complete history. | ||
Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | |
Annotation program | Chordata Protein Annotation Program | |
Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. |
Miscellaneousi
Keywords - Technical termi
3D-structure, Reference proteomeDocuments
- Human chromosome 15
Human chromosome 15: entries, gene names and cross-references to MIM - Human entries with genetic variants
List of human entries with genetic variants - Human variants curated from literature reports
Index of human variants curated from literature reports - MIM cross-references
Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot - PDB cross-references
Index of Protein Data Bank (PDB) cross-references - SIMILARITY comments
Index of protein domains and families